Neutrophil F-actin dynamics in Familial Mediterranean Fever: the unequal effect of colchicine on activated

Tigran K Davtyan1, Samvel A Avetisyan, Gagik S Hakobyan

  • 1Laboratory of Immunology and Virology, "Armenicum" Research Centre, CJSC Armenicum, 37 Nalbandyan str., Yerevan 0001, Republic of Armenia. tigdav@excite.com

Insights

Familial Mediterranean Fever (FMF) neutrophils show impaired F-actin dynamics and cellular adaptation to chemoattractant stimuli. This dysfunction in neutrophil F-actin and phagocytosis may be a key therapeutic target for FMF.

Area of Science:

  • Immunology
  • Cell Biology
  • Genetics

Background:

  • Familial Mediterranean Fever (FMF) pathogenesis involves neutrophil activation and chemotaxis.
  • MEFV gene mutations are linked to FMF and may affect neutrophil function.

Purpose of the Study:

  • Investigate neutrophil F-actin, phagocytosis, and macropinocytosis dynamics in FMF patients.
  • Understand the impact of MEFV mutations on neutrophil response to chemoattractants.
  • Evaluate the effect of colchicine on neutrophil dynamics in FMF.

Main Methods:

  • Analysis of neutrophil F-actin content and dynamics in FMF patients and healthy donors.
  • Assessment of phagocytosis and macropinocytosis in neutrophils.
  • Examination of neutrophil response to varying chemoattractant concentrations.
  • Evaluation of colchicine's effect on neutrophil F-actin dynamics.

Main Results:

  • FMF neutrophils exhibit increased basal F-actin but reduced activation-dependent F-actin dynamics.
  • FMF neutrophils show altered responses to chemoattractant stimuli compared to healthy controls.
  • Phagocytosis and macropinocytosis dynamics are transiently increased in FMF neutrophils.
  • Colchicine differentially affects neutrophil F-actin dynamics in FMF patients versus healthy donors.

Conclusions:

  • MEFV mutations disrupt neutrophil cellular adaptation to chemoattractant stimuli.
  • Altered neutrophil F-actin and phagocytosis dynamics are central to FMF pathogenesis.
  • These neutrophil dysfunctions represent potential therapeutic targets for FMF treatment.